Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls

Acta Psychiatrica Scandinavica

Volumn 133, Issue 1, 2016, Pages 44-52

  Quintana, D S ^a   Westlye, L T ^a,b   Kaufmann, T ^a   Rustan, Ø G ^a   Brandt, C L ^a   Haatveit, B ^a   Steen, N E ^a,c   Andreassen, O A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

Autonomic nervous system; Bipolar disorder; Heart rate variability; Schizophrenia

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTICENTER STUDY; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RISK FACTOR; RISK REDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCREENING TEST; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; HEART; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AUTONOMIC NERVOUS SYSTEM; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HEART; HEART RATE; HUMANS; MALE; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 84954391756     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12498     Document Type: Article

References (76)

1. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627.
2. McGrath J, Saha S, Welham J, El Saadi O, Maccauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2004;2:13.
3. Bramon E, Sham PC. The common genetic liability between schizophrenia and bipolar disorder: a review. Curr Psychiatry Rep 2001;3:332-337.
4. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull 2011;37:73-83.
5. Seidman LJ, Kremen WS, Koren D, Faraone SV, Goldstein JM, Tsuang MT. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr Res 2002;53:31-44.
6. Singh J, Chen G, Canuso CM. Antipsychotics in the treatment of bipolar disorder. In: Gross G, Geyer MA, eds. Current Antipsychotics. Berlin: Spinger, 2012.
7. Lichtenstein P, Yip BH, Björk C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234-239.
8. Andreassen OA, Thompson WK, Schork AJ et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet 2013;9:e1003455.
9. Tsuang MT, Winokur G, Crowe RR. Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry 1980;137:497-504.
10. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 2005;186:364-366.
11. Lawrie SM, Hall J, McIntosh AM, Owens DG, Johnstone EC. The 'continuum of psychosis': scientifically unproven and clinically impractical. Br J Psychiatry 2010;197:423-425.
12. Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011;131:101-104.
13. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 2011;49:599-604.
14. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-1121.
15. Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008;20:131-137.
16. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011;23:40.
17. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA 2007;298:1794-1796.
18. Manu P, Dima L, Shulman M, Vancampfort D, de Hert M, Correll C. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand 2015;132:97-108.
19. Birkenaes AB, Opjordsmoen S, Brunborg C et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007;68:917-923.
20. Young AH, Grunze H. Physical health of patients with bipolar disorder. Acta Psychiatr Scand 2013;127:3-10.
21. Filik R, Sipos A, Kehoe P et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 2006;113:298-305.
22. Andreassen OA, Djurovic S, Thompson WK et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013;92:197-209.
23. Koponen H, Alaräisänen A, Saari K et al. Schizophrenia and sudden cardiac death - a review. Nord J Psychiatry 2008;62:342-345.
24. Camm A, Malik M, Bigger J et al. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-1065.
25. Bigger J, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 1993;88:927-934.
26. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262.
27. Tsuji H, Larson MG, Venditti FJ et al. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 1996;94:2850-2855.
28. Bar KJ, Wernich K, Boettger S et al. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res 2008;157:255-257.
29. Jindal RD, Keshavan MS, Eklund K, Stevens A, Montrose DM, Yeragani VK. Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res 2009;113:176-180.
30. Cohen H, Loewenthal U, Matar M, Kotler M. Association of autonomic dysfunction and clozapine heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 2001;179:167-171.
31. Chang JS, Yoo CS, Yi SH et al. Differential pattern of heart rate variability in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:991-995.
32. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993;88:791-804.
33. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261.
34. Spitzer RL, Williams JB, Kroenke K et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1756.
35. Gil E, Orini M, Bailón R, Vergara J, Mainardi L, Laguna P. Photoplethysmography pulse rate variability as a surrogate measurement of heart rate variability during non-stationary conditions. Physiol Meas 2010;31:1271.
36. Lu G, Yang F, Taylor J, Stein J. A comparison of photoplethysmography and ECG recording to analyse heart rate variability in healthy subjects. J Med Eng Technol 2009;33:634-641.
37. Selvaraj N, Jaryal A, Santhosh J, Deepak KK, Anand S. Assessment of heart rate variability derived from finger-tip photoplethysmography as compared to electrocardiography. J Med Eng Technol 2008;32:479-484.
38. Kaufmann T, Sütterlin S, Schulz SM, Vögele C. ARTiiFACT: a tool for heart rate artifact processing and heart rate variability analysis. Behav Res Methods 2011;43:1161-1170.
39. Berntson GG, Quigley KS, Jang JF, Boysen ST. An approach to artifact identification: application to heart period data. Psychophysiology 1990;27:586-598.
40. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger A, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
41. Kamath MV, Fallen EL. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng 1992;21:245-311.
42. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2014.
43. Koskinen T, Kähönen M, Jula A et al. Short-term heart rate variability in healthy young adults: the Cardiovascular Risk in Young Finns Study. Auton Neurosci 2009;145:81-88.
44. Quintana DS, Heathers JAJ. Considerations in the assessment of heart rate variability in biobehavioral research. Front Psychol 2014;5:805.
45. Sacha J. Why should one normalize heart rate variability with respect to average heart rate. Front Physiol 2013;4:1-2.
46. Dienes Z. Using Bayes to get the most out of non-significant results. Front Psychol 2014;5:1-17.
47. Goodman SN. Toward evidence-based medical statistics. 2: the Bayes factor. Ann Intern Med 1999;130:1005-1013.
48. Huang WL, Chang LR, Kuo TBJ, Lin YH, Chen YZ, Yang CCH. Impact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophrenia. J Clin Psychopharmacol 2013;33:170-177.
49. Neter J, Wasserman W, Kutner MH. Applied linear regression models. Homewood, IL: Irwin, 1989.
50. Tabachnick BG, Fidell LS. Using multivariate statistics. Boston, MA: Allyn and Bacon, 2001.
51. Ward JH Jr. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963;58:236-244.
52. Freudenreich O, Charles Schulz S, Goff DC. Initial medical work-up of first-episode psychosis: a conceptual review. Early Interv Psychiatry 2009;3:10-18.
53. Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. The Journal of clinical psychiatry. 2005;67:25-30.
54. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2011;8:114-126.
55. Mitchell A, Delaffon V, Vancampfort D, Correll C, De Hert M. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2012;42:125-147.
56. Quintana DS, Kemp AH, Alvares GA, Guastella AJ. A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness. Front Neurosci 2013;7:1-9.
57. Porges SW. Orienting in a defensive world: mammalian modifications of our evolutionary heritage. A polyvagal theory. Psychophysiology 1995;32:301-318.
58. Bal E, Harden E, Lamb D, Van Hecke AV, Denver JW, Porges SW. Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J Autism Dev Disord 2010;40:358-370.
59. Francis HM, Fisher A, Rushby JA, McDonald S. Reduced heart rate variability in chronic severe traumatic brain injury: association with impaired emotional and social functioning, and potential for treatment using biofeedback. Neuropsychol Rehabil 2016;26:103-25.
60. Diamond LM, Hicks AM, Otter-Henderson KD. Individual differences in vagal regulation moderate associations between daily affect and daily couple interactions. Pers Soc Psychol Bull 2011;36:731-744.
61. Diamond LM, Hicks AM. Attachment style, current relationship security, and negative emotions: the mediating role of physiological regulation. J Soc Pers Relat 2005;22:499-518.
62. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr Res 2004;71:227-237.
63. Velthorst E, Nieman DH, Becker HE et al. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 2009;109:60-65.
64. Thayer JF, Åhs F, Fredrikson M, Sollers JJ, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev 2012;36:747-756.
65. Williams LM, Das P, Harris AW et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004;161:480-489.
66. Anticevic A, Brumbaugh MS, Winkler AM et al. Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry 2013;73:565-573.
67. Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol 2007;74:224-242.
68. Pinkham AE, Hopfinger JB, Pelphrey KA, Piven J, Penn DL. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res 2008;99:164-175.
69. Aleman A, Kahn RS. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 2005;77:283-298.
70. Li H, Chan RC, McAlonan GM. Gong Q-Y. Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophr Bull 2010;36:1029-1039.
71. Vaccarino V, Lampert R, Bremner JD et al. Depressive symptoms and heart rate variability: evidence for a shared genetic substrate in a study of twins. Psychosom Med 2008;70:628-636.
72. Kupper NH, Willemsen G, van den Berg M et al. Heritability of ambulatory heart rate variability. Circulation 2004;110:2792-2796.
73. Singh JP, Larson MG, O'Donnell CJ, Tsuji H, Evans JC, Levy D. Heritability of heart rate variability: the Framingham Heart Study. Circulation 1999;99:2251-2254.
74. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res 2010;44:168-176.
75. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-2217.
76. Cohen H, Kaplan Z, Kotler M, Mittelman I, Osher Y, Bersudsky Y. Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord 2003;5:138-143.